Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England

Authors: Whiteley, William N. ;

Ip, Samantha;

Cooper, Jennifer A.;

Bolton, Thomas;

Keene, Spencer;

Walker, Venexia;

Denholm, Rachel;

Akbari, Ashley;

Omigie, Efosa;

Hollings, Sam;

Di Angelantonio, Emanuele;

Denaxas, Spiros ;

Wood, Angela;

Sterne, Jonathan A. C.;

Sudlow, Cathie L.M.;

CVD-COVID-UK Consortium

Source: PLoS Medicine

Full text

: https://doi.org/10.1371/journal.pmed.1003926

Abstract

Rights

This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Cite as

Whiteley, W., Ip, S., Cooper, J., Bolton, T., Keene, S., Walker, V., Denholm, R., Akbari, A., Omigie, E., Hollings, S., Di Angelantonio, E., Denaxas, S., Wood, A., Sterne, J., Sudlow, C. & CVD-COVID-UK Consortium 2022, 'Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England', PLoS Medicine, 19(2), article no: e1003926. https://doi.org/10.1371/journal.pmed.1003926

Downloadable citations

HTML BIB RIS

Identifiers

DOI: https://doi.org/10.1371/journal.pmed.1003926

Repository URI: https://www.research.ed.ac.uk/en/publications/570b67d8-4a56-4c5b-9124-3ad71a6075cd